Le Lézard
Classified in: Health
Subjects: PDT, SVY, BFA

A Fundamental Scientific Study on The Effect of Synthesit Iron With Vitamin B6 Has Been Published


The year 2024 showed a great start for Synthesit Swiss SA. 

GENEVA, Feb. 27, 2024 /PRNewswire/ -- On 15. January 2024 Frontiers in Nutrition, one of the most respected scientific Swiss journals, published a research article on the long term effect of iron supplementation combined with vitamin B6 on the maximum oxygen consumption and energy production. Iron is an essential micronutrient. It plays a vital part in many biological processes. The research shows that iron supplementation increases ATP synthesis in muscle mitochondria by more than 60% and brain mitochondria by more than 30%, and also increases maximum oxygen consumption by more than 10%. 

Furthermore, a case report cited in "Acta Medica Martiniana", a European scientific journal, depicts a clinical case of a patient with pancreatic cancer. It shows how Synthesit alleviates intoxication during chemotherapy. 

Synthesit Swiss SA is engaged in recreating natural processes in the laboratory. In 2019 it created a new biogenic iron, called SYNTHESIT. This iron-based mineral portrays completely different principles of action, in comparison to regular iron preparations. Synthesit activates the body's internal resources. Find the original research articles here: 

https://www.frontiersin.org/articles/10.3389/fnut.2023.1335187/full
https://sciendo.com/article/10.2478/acm-2023-0014 

Contact:
Lisa Petzold
Synthesit Swiss SA
+ 41225330507
373530@email4pr.com

SOURCE Synthesit Swiss SA


These press releases may also interest you

at 00:20
PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA
PROTEINA announced today that it has held a kickoff meeting with Professor Janghee Woo and his research team at Emory University School of Medicine in Atlanta, to begin global clinical validation of its flagship product, PPI PathFinder BCL2 Dx. PPI...

at 00:00
INTREPID Alliance Landscape of Promising Antivirals in Clinical Development Reveals Gaps in Global Defense Against Potential Future Pandemics
Building on its commitment to identify strengths and gaps in the R&D pipeline for antivirals, the INTREPID Alliance, a consortium of innovative biopharmaceutical companies dedicated to accelerating antiviral treatments to help protect the world ahead...

at 00:00
SPECTRUM DYNAMICS MEDICAL AND HERMES MEDICAL SOLUTIONS ENTER INTO PARTNERSHIP TO OFFER INTEGRATED SOLUTION OF THE HERMIA SOFTWARE WITH THE VERITON-CT SCANNER
Spectrum Dynamic's customers will...

28 avr 2024
AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer's Disease (POLARIS-AD)
AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzheimer's disease clinical trial. EMA now aligns with the U.S. Food and Drug Administration (FDA)...

28 avr 2024
Celltrion USA signs agreement with Express Scripts for its therapy for autoimmune diseases including the first FDA-approved subcutaneous infliximab ZYMFENTRAtm
Celltrion USA announced today that it has signed an agreement with Express Scripts, one of the nation's leading pharmacy benefit managers (PBMs) negotiating on behalf of health plans covering more than 100 million people. The agreement, effective...

28 avr 2024
Marc Dubrick and Lisa Becharas Win St. Anthony's Triathlon
Marc Dubrick and Lisa Becharas are bringing victories home to Boulder, Colorado, after winning their first St. Anthony's Triathlon along St. Petersburg's scenic downtown waterfront. The winners, who are teammates on The Real Triathlon Squad, raced a...

More news about Health...


News published on and distributed by: